AptaBio Therapeutics Statistics

Total Valuation

KOSDAQ:293780 has a market cap or net worth of KRW 202.15 billion. The enterprise value is 178.15 billion.

Market Cap	202.15B
Enterprise Value	178.15B

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:293780 has 26.88 million shares outstanding. The number of shares has increased by 3.83% in one year.

Current Share Class	n/a
Shares Outstanding	26.88M
Shares Change (YoY)	+3.83%
Shares Change (QoQ)	+14.85%
Owned by Insiders (%)	28.45%
Owned by Institutions (%)	3.00%
Float	18.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	52.67
PB Ratio	3.73
P/TBV Ratio	3.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.06
EV / Sales	53.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.37

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.14.

Current Ratio	1.79
Quick Ratio	1.67
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	-0.61
Interest Coverage	-6.09

Financial Efficiency

Return on equity (ROE) is -50.84% and return on invested capital (ROIC) is -18.90%.

Return on Equity (ROE)	-50.84%
Return on Assets (ROA)	-15.24%
Return on Invested Capital (ROIC)	-18.90%
Return on Capital Employed (ROCE)	-35.78%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	32
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.57% in the last 52 weeks. The beta is 1.64, so KOSDAQ:293780's price volatility has been higher than the market average.

Beta (5Y)	1.64
52-Week Price Change	+3.57%
50-Day Moving Average	7,459.00
200-Day Moving Average	8,180.90
Relative Strength Index (RSI)	47.43
Average Volume (20 Days)	63,418

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:293780 had revenue of KRW 3.36 billion and -29.38 billion in losses. Loss per share was -1,248.00.

Revenue	3.36B
Gross Profit	273.69M
Operating Income	-20.72B
Pretax Income	-27.80B
Net Income	-29.38B
EBITDA	-20.18B
EBIT	-20.72B
Loss Per Share	-1,248.00

Full Income Statement

Balance Sheet

The company has 31.52 billion in cash and 7.52 billion in debt, giving a net cash position of 23.99 billion or 892.59 per share.

Cash & Cash Equivalents	31.52B
Total Debt	7.52B
Net Cash	23.99B
Net Cash Per Share	892.59
Equity (Book Value)	54.20B
Book Value Per Share	2,016.16
Working Capital	15.40B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.16 billion and capital expenditures -240.16 million, giving a free cash flow of -12.40 billion.

Operating Cash Flow	-12.16B
Capital Expenditures	-240.16M
Free Cash Flow	-12.40B
FCF Per Share	-461.28

Full Cash Flow Statement

Margins

Gross Margin	8.14%
Operating Margin	-616.35%
Pretax Margin	-827.22%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:293780 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.83%
Shareholder Yield	-3.83%
Earnings Yield	-14.53%
FCF Yield	-6.13%

Stock Splits

The last stock split was on August 24, 2021. It was a forward split with a ratio of 2.

Last Split Date	Aug 24, 2021
Split Type	Forward
Split Ratio	2

Scores

KOSDAQ:293780 has an Altman Z-Score of 2.06. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.06
Piotroski F-Score	n/a